nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—NQO1—Doxorubicin—thyroid cancer	0.432	0.612	CbGbCtD
Menadione—XDH—Doxorubicin—thyroid cancer	0.226	0.32	CbGbCtD
Menadione—CYP1A2—Sorafenib—thyroid cancer	0.0485	0.0686	CbGbCtD
Menadione—BGLAP—parathyroid gland—thyroid cancer	0.0311	0.144	CbGeAlD
Menadione—BGLAP—neck—thyroid cancer	0.00942	0.0435	CbGeAlD
Menadione—VKORC1L1—trachea—thyroid cancer	0.00915	0.0423	CbGeAlD
Menadione—VKORC1L1—thyroid gland—thyroid cancer	0.00724	0.0334	CbGeAlD
Menadione—F7—head—thyroid cancer	0.00681	0.0315	CbGeAlD
Menadione—PROS1—saliva-secreting gland—thyroid cancer	0.00681	0.0315	CbGeAlD
Menadione—F9—head—thyroid cancer	0.00651	0.0301	CbGeAlD
Menadione—VKORC1L1—head—thyroid cancer	0.00642	0.0297	CbGeAlD
Menadione—MTHFR—neck—thyroid cancer	0.00585	0.0271	CbGeAlD
Menadione—F2—neck—thyroid cancer	0.00585	0.0271	CbGeAlD
Menadione—PROS1—trachea—thyroid cancer	0.00525	0.0243	CbGeAlD
Menadione—NQO1—neck—thyroid cancer	0.00488	0.0226	CbGeAlD
Menadione—NQO2—saliva-secreting gland—thyroid cancer	0.00455	0.021	CbGeAlD
Menadione—VKORC1L1—lymph node—thyroid cancer	0.00449	0.0208	CbGeAlD
Menadione—BGLAP—thyroid gland—thyroid cancer	0.00448	0.0207	CbGeAlD
Menadione—GGCX—thyroid gland—thyroid cancer	0.00437	0.0202	CbGeAlD
Menadione—PROS1—thyroid gland—thyroid cancer	0.00416	0.0192	CbGeAlD
Menadione—BGLAP—head—thyroid cancer	0.00398	0.0184	CbGeAlD
Menadione—F10—thyroid gland—thyroid cancer	0.00391	0.0181	CbGeAlD
Menadione—GGCX—head—thyroid cancer	0.00388	0.0179	CbGeAlD
Menadione—NQO1—saliva-secreting gland—thyroid cancer	0.00381	0.0176	CbGeAlD
Menadione—VKORC1—thyroid gland—thyroid cancer	0.00375	0.0173	CbGeAlD
Menadione—PROS1—head—thyroid cancer	0.00369	0.017	CbGeAlD
Menadione—NQO2—trachea—thyroid cancer	0.00351	0.0162	CbGeAlD
Menadione—F10—head—thyroid cancer	0.00347	0.016	CbGeAlD
Menadione—VKORC1—head—thyroid cancer	0.00333	0.0154	CbGeAlD
Menadione—NQO1—trachea—thyroid cancer	0.00294	0.0136	CbGeAlD
Menadione—MTHFR—thyroid gland—thyroid cancer	0.00279	0.0129	CbGeAlD
Menadione—NQO2—thyroid gland—thyroid cancer	0.00278	0.0128	CbGeAlD
Menadione—GGCX—lymph node—thyroid cancer	0.00272	0.0126	CbGeAlD
Menadione—AOX1—trachea—thyroid cancer	0.0027	0.0125	CbGeAlD
Menadione—MAOB—saliva-secreting gland—thyroid cancer	0.00269	0.0124	CbGeAlD
Menadione—PROS1—lymph node—thyroid cancer	0.00258	0.0119	CbGeAlD
Menadione—F2—head—thyroid cancer	0.00247	0.0114	CbGeAlD
Menadione—MTHFR—head—thyroid cancer	0.00247	0.0114	CbGeAlD
Menadione—NQO2—head—thyroid cancer	0.00246	0.0114	CbGeAlD
Menadione—F10—lymph node—thyroid cancer	0.00243	0.0112	CbGeAlD
Menadione—VKORC1—lymph node—thyroid cancer	0.00233	0.0108	CbGeAlD
Menadione—NQO1—thyroid gland—thyroid cancer	0.00232	0.0107	CbGeAlD
Menadione—AOX1—thyroid gland—thyroid cancer	0.00213	0.00986	CbGeAlD
Menadione—NQO1—head—thyroid cancer	0.00206	0.00953	CbGeAlD
Menadione—MTHFR—lymph node—thyroid cancer	0.00173	0.008	CbGeAlD
Menadione—NQO2—lymph node—thyroid cancer	0.00172	0.00797	CbGeAlD
Menadione—MAOB—thyroid gland—thyroid cancer	0.00164	0.00759	CbGeAlD
Menadione—CYP1A1—trachea—thyroid cancer	0.00146	0.00674	CbGeAlD
Menadione—MAOB—head—thyroid cancer	0.00146	0.00674	CbGeAlD
Menadione—NQO1—lymph node—thyroid cancer	0.00144	0.00667	CbGeAlD
Menadione—Thalidomide—PTGS2—thyroid cancer	0.00136	1	CrCbGaD
Menadione—AOX1—lymph node—thyroid cancer	0.00132	0.00612	CbGeAlD
Menadione—CYP1A2—thyroid gland—thyroid cancer	0.00117	0.00541	CbGeAlD
Menadione—CYP1A1—thyroid gland—thyroid cancer	0.00115	0.00533	CbGeAlD
Menadione—CYP2E1—thyroid gland—thyroid cancer	0.00105	0.00486	CbGeAlD
Menadione—CYP1A1—head—thyroid cancer	0.00102	0.00473	CbGeAlD
Menadione—MAOB—lymph node—thyroid cancer	0.00102	0.00472	CbGeAlD
Menadione—CYP2E1—head—thyroid cancer	0.000933	0.00431	CbGeAlD
Menadione—CYP1A1—lymph node—thyroid cancer	0.000717	0.00331	CbGeAlD
Menadione—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	0.00018	0.00239	CbGpPWpGaD
Menadione—MTHFR—Disease—TCF7L1—thyroid cancer	0.00018	0.00238	CbGpPWpGaD
Menadione—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00018	0.00238	CbGpPWpGaD
Menadione—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000179	0.00237	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—PTCH1—thyroid cancer	0.000178	0.00236	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TP53—thyroid cancer	0.000177	0.00235	CbGpPWpGaD
Menadione—AOX1—Disease—TCF7L1—thyroid cancer	0.000175	0.00233	CbGpPWpGaD
Menadione—XDH—Metabolism—HPGD—thyroid cancer	0.000174	0.00231	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	0.000173	0.0023	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000173	0.0023	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.00017	0.00225	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.000168	0.00222	CbGpPWpGaD
Menadione—CYP2A6—Biological oxidations—RXRA—thyroid cancer	0.000163	0.00216	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—SST—thyroid cancer	0.000163	0.00216	CbGpPWpGaD
Menadione—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000162	0.00215	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	0.00016	0.00213	CbGpPWpGaD
Menadione—MAOB—Metabolism—HPGD—thyroid cancer	0.000158	0.0021	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—CALCA—thyroid cancer	0.000156	0.00208	CbGpPWpGaD
Menadione—F9—Hemostasis—NRAS—thyroid cancer	0.000149	0.00197	CbGpPWpGaD
Menadione—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000146	0.00193	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.000144	0.00191	CbGpPWpGaD
Menadione—PROS1—Immune System—CDK1—thyroid cancer	0.000142	0.00188	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CALCB—thyroid cancer	0.000137	0.00182	CbGpPWpGaD
Menadione—PROS1—Immune System—IFNA2—thyroid cancer	0.000136	0.00181	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000135	0.00179	CbGpPWpGaD
Menadione—MTHFR—Disease—TPR—thyroid cancer	0.000131	0.00174	CbGpPWpGaD
Menadione—F7—Hemostasis—NRAS—thyroid cancer	0.000131	0.00173	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TRIM33—thyroid cancer	0.00013	0.00172	CbGpPWpGaD
Menadione—MTHFR—Disease—PRKAR1A—thyroid cancer	0.000129	0.00172	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000129	0.00171	CbGpPWpGaD
Menadione—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000129	0.00171	CbGpPWpGaD
Menadione—AOX1—Disease—TPR—thyroid cancer	0.000128	0.0017	CbGpPWpGaD
Menadione—F9—Hemostasis—KRAS—thyroid cancer	0.000128	0.0017	CbGpPWpGaD
Menadione—AOX1—Disease—PRKAR1A—thyroid cancer	0.000126	0.00168	CbGpPWpGaD
Menadione—MTHFR—Disease—MEN1—thyroid cancer	0.000124	0.00164	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000123	0.00163	CbGpPWpGaD
Menadione—F2—Hemostasis—IFNA2—thyroid cancer	0.000122	0.00162	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000121	0.00161	CbGpPWpGaD
Menadione—CYP1A1—Biological oxidations—RXRA—thyroid cancer	0.000121	0.00161	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	0.000121	0.0016	CbGpPWpGaD
Menadione—AOX1—Disease—MEN1—thyroid cancer	0.000121	0.0016	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—MINPP1—thyroid cancer	0.00012	0.00159	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—TSHR—thyroid cancer	0.000118	0.00157	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000117	0.00155	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000116	0.00154	CbGpPWpGaD
Menadione—F9—Hemostasis—TP53—thyroid cancer	0.000114	0.00151	CbGpPWpGaD
Menadione—PROS1—Immune System—NRG1—thyroid cancer	0.000114	0.00151	CbGpPWpGaD
Menadione—F7—Hemostasis—KRAS—thyroid cancer	0.000112	0.00149	CbGpPWpGaD
Menadione—NQO1—Metabolism—TPR—thyroid cancer	0.000111	0.00148	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.00011	0.00146	CbGpPWpGaD
Menadione—MTHFR—Metabolism—TPR—thyroid cancer	0.00011	0.00146	CbGpPWpGaD
Menadione—NQO1—Metabolism—PRKAR1A—thyroid cancer	0.00011	0.00146	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	0.00011	0.00145	CbGpPWpGaD
Menadione—PROC—Hemostasis—NRAS—thyroid cancer	0.000109	0.00145	CbGpPWpGaD
Menadione—F9—Hemostasis—HRAS—thyroid cancer	0.000109	0.00144	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PRKAR1A—thyroid cancer	0.000108	0.00144	CbGpPWpGaD
Menadione—AOX1—Metabolism—TPR—thyroid cancer	0.000108	0.00143	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—TSHR—thyroid cancer	0.000107	0.00142	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000107	0.00142	CbGpPWpGaD
Menadione—AOX1—Metabolism—PRKAR1A—thyroid cancer	0.000106	0.0014	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000106	0.0014	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	0.000104	0.00138	CbGpPWpGaD
Menadione—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000103	0.00137	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—NDUFA13—thyroid cancer	0.000102	0.00135	CbGpPWpGaD
Menadione—XDH—Metabolism—TPR—thyroid cancer	0.0001	0.00133	CbGpPWpGaD
Menadione—F7—Hemostasis—TP53—thyroid cancer	9.98e-05	0.00132	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	9.85e-05	0.00131	CbGpPWpGaD
Menadione—MTHFR—Disease—CALCA—thyroid cancer	9.84e-05	0.00131	CbGpPWpGaD
Menadione—XDH—Metabolism—PRKAR1A—thyroid cancer	9.84e-05	0.00131	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—PTEN—thyroid cancer	9.77e-05	0.0013	CbGpPWpGaD
Menadione—PROS1—Hemostasis—NRAS—thyroid cancer	9.68e-05	0.00128	CbGpPWpGaD
Menadione—AOX1—Disease—CALCA—thyroid cancer	9.61e-05	0.00128	CbGpPWpGaD
Menadione—F9—Hemostasis—AKT1—thyroid cancer	9.6e-05	0.00127	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CHST14—thyroid cancer	9.56e-05	0.00127	CbGpPWpGaD
Menadione—F7—Hemostasis—HRAS—thyroid cancer	9.55e-05	0.00127	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—MINPP1—thyroid cancer	9.45e-05	0.00125	CbGpPWpGaD
Menadione—PROC—Hemostasis—KRAS—thyroid cancer	9.41e-05	0.00125	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—SST—thyroid cancer	9.18e-05	0.00122	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PTCH1—thyroid cancer	9.12e-05	0.00121	CbGpPWpGaD
Menadione—MAOB—Metabolism—TPR—thyroid cancer	9.09e-05	0.00121	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	9.01e-05	0.0012	CbGpPWpGaD
Menadione—MAOB—Metabolism—PRKAR1A—thyroid cancer	8.94e-05	0.00119	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—MINPP1—thyroid cancer	8.91e-05	0.00118	CbGpPWpGaD
Menadione—MTHFR—Disease—CDK1—thyroid cancer	8.91e-05	0.00118	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—CALCA—thyroid cancer	8.84e-05	0.00117	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—NRAS—thyroid cancer	8.72e-05	0.00116	CbGpPWpGaD
Menadione—AOX1—Disease—CDK1—thyroid cancer	8.7e-05	0.00115	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TCF7L1—thyroid cancer	8.66e-05	0.00115	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	8.58e-05	0.00114	CbGpPWpGaD
Menadione—F7—Hemostasis—AKT1—thyroid cancer	8.43e-05	0.00112	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—thyroid cancer	8.37e-05	0.00111	CbGpPWpGaD
Menadione—NQO1—Metabolism—SLC5A5—thyroid cancer	8.34e-05	0.00111	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—SST—thyroid cancer	8.34e-05	0.00111	CbGpPWpGaD
Menadione—PROS1—Hemostasis—KRAS—thyroid cancer	8.33e-05	0.00111	CbGpPWpGaD
Menadione—MTHFR—Metabolism—SLC5A5—thyroid cancer	8.24e-05	0.00109	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.22e-05	0.00109	CbGpPWpGaD
Menadione—AOX1—Metabolism—SLC5A5—thyroid cancer	8.05e-05	0.00107	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NDUFA13—thyroid cancer	8.04e-05	0.00107	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CALCA—thyroid cancer	8.03e-05	0.00107	CbGpPWpGaD
Menadione—PROC—Hemostasis—HRAS—thyroid cancer	8e-05	0.00106	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	7.75e-05	0.00103	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—RXRA—thyroid cancer	7.73e-05	0.00103	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—HPGD—thyroid cancer	7.71e-05	0.00102	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NDUFA13—thyroid cancer	7.58e-05	0.00101	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CHST14—thyroid cancer	7.56e-05	0.001	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—KRAS—thyroid cancer	7.5e-05	0.000995	CbGpPWpGaD
Menadione—XDH—Metabolism—SLC5A5—thyroid cancer	7.48e-05	0.000993	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—thyroid cancer	7.41e-05	0.000983	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	7.39e-05	0.00098	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	7.38e-05	0.00098	CbGpPWpGaD
Menadione—F10—Hemostasis—NRAS—thyroid cancer	7.38e-05	0.000979	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CDK1—thyroid cancer	7.27e-05	0.000964	CbGpPWpGaD
Menadione—MTHFR—Disease—NRG1—thyroid cancer	7.15e-05	0.000949	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CHST14—thyroid cancer	7.12e-05	0.000945	CbGpPWpGaD
Menadione—PROS1—Hemostasis—HRAS—thyroid cancer	7.08e-05	0.00094	CbGpPWpGaD
Menadione—PROC—Hemostasis—AKT1—thyroid cancer	7.07e-05	0.000938	CbGpPWpGaD
Menadione—NQO1—Metabolism—RXRA—thyroid cancer	7.01e-05	0.00093	CbGpPWpGaD
Menadione—AOX1—Disease—NRG1—thyroid cancer	6.98e-05	0.000927	CbGpPWpGaD
Menadione—MTHFR—Metabolism—RXRA—thyroid cancer	6.92e-05	0.000919	CbGpPWpGaD
Menadione—MAOB—Metabolism—SLC5A5—thyroid cancer	6.8e-05	0.000903	CbGpPWpGaD
Menadione—AOX1—Metabolism—RXRA—thyroid cancer	6.76e-05	0.000898	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	6.59e-05	0.000874	CbGpPWpGaD
Menadione—MTHFR—Disease—TERT—thyroid cancer	6.42e-05	0.000852	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HRAS—thyroid cancer	6.38e-05	0.000846	CbGpPWpGaD
Menadione—F10—Hemostasis—KRAS—thyroid cancer	6.35e-05	0.000842	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TSHR—thyroid cancer	6.34e-05	0.000841	CbGpPWpGaD
Menadione—XDH—Metabolism—RXRA—thyroid cancer	6.29e-05	0.000834	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	6.28e-05	0.000833	CbGpPWpGaD
Menadione—AOX1—Disease—TERT—thyroid cancer	6.27e-05	0.000832	CbGpPWpGaD
Menadione—PROS1—Hemostasis—AKT1—thyroid cancer	6.25e-05	0.00083	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PRKAR1A—thyroid cancer	6.23e-05	0.000827	CbGpPWpGaD
Menadione—MTHFR—Disease—HIF1A—thyroid cancer	6.14e-05	0.000815	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—HPGD—thyroid cancer	6.09e-05	0.000808	CbGpPWpGaD
Menadione—AOX1—Disease—HIF1A—thyroid cancer	6e-05	0.000796	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MEN1—thyroid cancer	5.96e-05	0.00079	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—HPGD—thyroid cancer	5.74e-05	0.000762	CbGpPWpGaD
Menadione—MAOB—Metabolism—RXRA—thyroid cancer	5.71e-05	0.000758	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	5.69e-05	0.000755	CbGpPWpGaD
Menadione—PROS1—Immune System—PTEN—thyroid cancer	5.69e-05	0.000755	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—MINPP1—thyroid cancer	5.68e-05	0.000754	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—thyroid cancer	5.64e-05	0.000749	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—AKT1—thyroid cancer	5.63e-05	0.000747	CbGpPWpGaD
Menadione—F10—Hemostasis—HRAS—thyroid cancer	5.4e-05	0.000716	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTCH1—thyroid cancer	5.39e-05	0.000715	CbGpPWpGaD
Menadione—MTHFR—Disease—BRAF—thyroid cancer	5.08e-05	0.000675	CbGpPWpGaD
Menadione—PROS1—Immune System—NRAS—thyroid cancer	5.08e-05	0.000674	CbGpPWpGaD
Menadione—AOX1—Disease—BRAF—thyroid cancer	4.97e-05	0.000659	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SST—thyroid cancer	4.93e-05	0.000654	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NDUFA13—thyroid cancer	4.83e-05	0.000641	CbGpPWpGaD
Menadione—F10—Hemostasis—AKT1—thyroid cancer	4.76e-05	0.000632	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CALCA—thyroid cancer	4.74e-05	0.000629	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.66e-05	0.000618	CbGpPWpGaD
Menadione—F2—Hemostasis—NRAS—thyroid cancer	4.54e-05	0.000603	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CHST14—thyroid cancer	4.54e-05	0.000603	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—TPR—thyroid cancer	4.43e-05	0.000587	CbGpPWpGaD
Menadione—NQO1—Metabolism—PPARG—thyroid cancer	4.43e-05	0.000587	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PPARG—thyroid cancer	4.37e-05	0.00058	CbGpPWpGaD
Menadione—PROS1—Immune System—KRAS—thyroid cancer	4.37e-05	0.00058	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	4.35e-05	0.000578	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CDK1—thyroid cancer	4.29e-05	0.00057	CbGpPWpGaD
Menadione—AOX1—Metabolism—PPARG—thyroid cancer	4.27e-05	0.000567	CbGpPWpGaD
Menadione—MTHFR—Disease—PTGS2—thyroid cancer	4.11e-05	0.000545	CbGpPWpGaD
Menadione—AOX1—Disease—PTGS2—thyroid cancer	4.01e-05	0.000532	CbGpPWpGaD
Menadione—XDH—Metabolism—PPARG—thyroid cancer	3.97e-05	0.000527	CbGpPWpGaD
Menadione—F2—Hemostasis—KRAS—thyroid cancer	3.91e-05	0.000519	CbGpPWpGaD
Menadione—PROS1—Immune System—HRAS—thyroid cancer	3.71e-05	0.000493	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—HPGD—thyroid cancer	3.66e-05	0.000486	CbGpPWpGaD
Menadione—MAOB—Metabolism—PPARG—thyroid cancer	3.61e-05	0.000479	CbGpPWpGaD
Menadione—MTHFR—Disease—PTEN—thyroid cancer	3.58e-05	0.000475	CbGpPWpGaD
Menadione—AOX1—Disease—PTEN—thyroid cancer	3.5e-05	0.000464	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—TPR—thyroid cancer	3.5e-05	0.000464	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTGS2—thyroid cancer	3.48e-05	0.000462	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—thyroid cancer	3.47e-05	0.000461	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRG1—thyroid cancer	3.45e-05	0.000457	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	3.44e-05	0.000457	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTGS2—thyroid cancer	3.44e-05	0.000456	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTGS2—thyroid cancer	3.36e-05	0.000446	CbGpPWpGaD
Menadione—F2—Hemostasis—HRAS—thyroid cancer	3.32e-05	0.000441	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—SLC5A5—thyroid cancer	3.31e-05	0.00044	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—TPR—thyroid cancer	3.3e-05	0.000438	CbGpPWpGaD
Menadione—PROS1—Immune System—AKT1—thyroid cancer	3.28e-05	0.000435	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	3.24e-05	0.000431	CbGpPWpGaD
Menadione—MTHFR—Disease—NRAS—thyroid cancer	3.2e-05	0.000424	CbGpPWpGaD
Menadione—XDH—Metabolism—PTGS2—thyroid cancer	3.12e-05	0.000414	CbGpPWpGaD
Menadione—AOX1—Disease—NRAS—thyroid cancer	3.12e-05	0.000414	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TERT—thyroid cancer	3.09e-05	0.000411	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTEN—thyroid cancer	3.04e-05	0.000403	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTEN—thyroid cancer	3e-05	0.000398	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.97e-05	0.000394	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HIF1A—thyroid cancer	2.96e-05	0.000393	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.94e-05	0.00039	CbGpPWpGaD
Menadione—F2—Hemostasis—AKT1—thyroid cancer	2.93e-05	0.000389	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTEN—thyroid cancer	2.93e-05	0.000389	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTGS2—thyroid cancer	2.84e-05	0.000377	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—RXRA—thyroid cancer	2.78e-05	0.000369	CbGpPWpGaD
Menadione—MTHFR—Disease—KRAS—thyroid cancer	2.75e-05	0.000365	CbGpPWpGaD
Menadione—XDH—Metabolism—PTEN—thyroid cancer	2.72e-05	0.000361	CbGpPWpGaD
Menadione—AOX1—Disease—KRAS—thyroid cancer	2.69e-05	0.000356	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—SLC5A5—thyroid cancer	2.62e-05	0.000347	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NRAS—thyroid cancer	2.61e-05	0.000346	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTEN—thyroid cancer	2.48e-05	0.000328	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—SLC5A5—thyroid cancer	2.47e-05	0.000328	CbGpPWpGaD
Menadione—F2—Signaling Pathways—BRAF—thyroid cancer	2.45e-05	0.000325	CbGpPWpGaD
Menadione—MTHFR—Disease—HRAS—thyroid cancer	2.34e-05	0.00031	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.31e-05	0.000307	CbGpPWpGaD
Menadione—AOX1—Disease—HRAS—thyroid cancer	2.28e-05	0.000303	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—KRAS—thyroid cancer	2.24e-05	0.000298	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—RXRA—thyroid cancer	2.2e-05	0.000292	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—TPR—thyroid cancer	2.1e-05	0.000279	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—RXRA—thyroid cancer	2.07e-05	0.000275	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.07e-05	0.000275	CbGpPWpGaD
Menadione—MTHFR—Disease—AKT1—thyroid cancer	2.06e-05	0.000274	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.02e-05	0.000268	CbGpPWpGaD
Menadione—AOX1—Disease—AKT1—thyroid cancer	2.02e-05	0.000268	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRAS—thyroid cancer	1.91e-05	0.000253	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.88e-05	0.000249	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—AKT1—thyroid cancer	1.85e-05	0.000246	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCND1—thyroid cancer	1.79e-05	0.000237	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PPARG—thyroid cancer	1.76e-05	0.000233	CbGpPWpGaD
Menadione—NQO1—Metabolism—AKT1—thyroid cancer	1.75e-05	0.000232	CbGpPWpGaD
Menadione—MTHFR—Metabolism—AKT1—thyroid cancer	1.73e-05	0.000229	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTEN—thyroid cancer	1.73e-05	0.000229	CbGpPWpGaD
Menadione—AOX1—Metabolism—AKT1—thyroid cancer	1.69e-05	0.000224	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AKT1—thyroid cancer	1.68e-05	0.000223	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.57e-05	0.000209	CbGpPWpGaD
Menadione—XDH—Metabolism—AKT1—thyroid cancer	1.57e-05	0.000208	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRAS—thyroid cancer	1.54e-05	0.000204	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.48e-05	0.000196	CbGpPWpGaD
Menadione—MAOB—Metabolism—AKT1—thyroid cancer	1.43e-05	0.000189	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000184	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.38e-05	0.000183	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KRAS—thyroid cancer	1.33e-05	0.000176	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—RXRA—thyroid cancer	1.32e-05	0.000176	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PPARG—thyroid cancer	1.31e-05	0.000174	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.29e-05	0.000171	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTEN—thyroid cancer	1.21e-05	0.00016	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—thyroid cancer	1.18e-05	0.000156	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRAS—thyroid cancer	1.13e-05	0.000149	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.09e-05	0.000145	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTGS2—thyroid cancer	1.03e-05	0.000137	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKT1—thyroid cancer	9.95e-06	0.000132	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTEN—thyroid cancer	9.53e-06	0.000126	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTEN—thyroid cancer	8.98e-06	0.000119	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PPARG—thyroid cancer	8.35e-06	0.000111	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKT1—thyroid cancer	6.95e-06	9.22e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTGS2—thyroid cancer	6.57e-06	8.72e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTEN—thyroid cancer	5.73e-06	7.6e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKT1—thyroid cancer	5.49e-06	7.29e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKT1—thyroid cancer	5.18e-06	6.87e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKT1—thyroid cancer	3.3e-06	4.38e-05	CbGpPWpGaD
